Breaking News Instant updates and real-time market news.

ZLAB

Zai Lab

, GSK

GlaxoSmithKline

09:26
06/12/19
06/12
09:26
06/12/19
09:26

Zai Lab announces approval to commercialize ZEJULA in Macau

Zai Lab (ZLAB) announced its approval to commercialize ZEJULA, an oral, once-daily poly polymerase inhibitor in Macau for adult patients with platinum-sensitive relapsed high grade serous epithelial ovarian cancer who are in a complete response or partial response on platinum-based chemotherapy. ZEJULA is a potent and highly selective PARP1/2 inhibitor that does not require BRCA mutation or other biomarker testing prior to administration. Zai Lab in-licensed rights to ZEJULA from Tesaro, which was recently acquired by GlaxoSmithKline (GSK), for China, Hong Kong and Macau as a new treatment option for patients who suffer from ovarian cancer in this region. Zai Lab obtained approval for marketing ZEJULA in Hong Kong in October 2018 and has been actively commercializing the product. In Mainland China, an NDA was accepted by the China's National Medical Products Administration on December 12, 2018, and was granted priority review status on January 28, 2019.

ZLAB

Zai Lab

GSK

GlaxoSmithKline

  • 12

    Jun

  • 13

    Jun

  • 20

    Jun

  • 29

    Aug

ZLAB Zai Lab

06/21/18
LEER
06/21/18
INITIATION
Target $43
LEER
Outperform
Zai Lab assumed with an Outperform at Leerink
Leerink analyst Jonathan Chang assumed coverage of Zai Lab with an Outperform rating and $43 price target as he believes it is well-positioned to execute.
11/21/18
JEFF
11/21/18
INITIATION
Target $34
JEFF
Buy
Zai Lab initiated with a Buy at Jefferies
Jefferies analyst Maury Raycroft started Zai Lab with a Buy rating and $34 price target. The analyst likes the company's structure of forming partnerships around assets that are already clinically de-risked. The partnerships reduce risk and allow Zai Lab to accelerate a drug's path to market in China, Raycroft tells investors in a research note.
01/29/19
FBCO
01/29/19
INITIATION
Target $34.7
FBCO
Outperform
Zai Lab initiated with an Outperform at Credit Suisse
Credit Suisse initiated Zai Lab with an Outperform and $34.70 price target.
02/07/19
SBSH
02/07/19
UPGRADE
SBSH
Buy
Citi double upgrades MacroGenics to Buy from Sell even after 130% stock rally
Citi analyst Yigal Nochomovitz double upgraded MacroGenics (MGNX) to Buy from Sell and raised his price target for the shares to $39 from $10. The stock closed yesterday up 130%, or $14.49, to $25.60. Following yesterday's data, the analyst raised his probability of success estimate to 70% from 50% for enoblituzumab in head and neck squamous cell carcinoma and non-small cell lung cancer. Additional Phase 1 readouts in 2019 should provide further stock momentum for MacroGenics, Nochomovitz tells investors in a research note. The analyst also sees MacroGenics as positive for Zai Lab (ZLAB). The Sophia data go a long way to validate Zai's choice of partner in MacroGenics, says the analyst.
GSK GlaxoSmithKline

01/31/19
WELS
01/31/19
NO CHANGE
WELS
Outperform
FDA approval of Mylan's Advair 'overdue,' says Wells Fargo
Wells Fargo analyst David Maris believes that while "overdue," FDA's approval of Mylan's (MYL) generic Advair is good news. Many investors were expecting this to be further delayed, he notes, adding that he currently has $50M generic Advair in his model for Q1. The analyst believes GlaxoSmithKline (GSK) will launch an authorized generic, and with Advair's already declining revenue, the generic Advair opportunity may turn out to be a great-to-have since it shows Mylan's ability to get complex generics approved, but may not be a game changer. Maris reiterates an Outperform rating on Mylan's shares.
02/01/19
WELS
02/01/19
NO CHANGE
Target $46
WELS
Market Perform
Perrigo's ProAir opportunity 'may be vaporizing,' says Wells Fargo
Wells Fargo analyst David Maris noted that GlaxoSmithKline (GSK) launched an authorized generic of Ventolin on January 15 and he has now learned that Teva (TEVA) may have "surprisingly launched" an authorized generic of ProAir in response to the generic Ventolin pressure prior to Perrigo's (PRGO) approval. Pricing pressure from generic Ventolin, in addition to the launch of an authorized generic well ahead of Perrigo's own generic ProAir launch, seem to have significantly diminished Perrigo's generic ProAir opportunity, Maris tells investors. He keeps a Market Perform rating and $46 price target on Perrigo shares.
02/22/19
UBSW
02/22/19
DOWNGRADE
UBSW
Neutral
GlaxoSmithKline downgraded to Neutral from Buy at UBS
UBS analyst Laura Sutcliffe downgraded GlaxoSmithKline to Neutral and lowered her price target for the shares to 1,650p from 1,700p. Concerns around the company's HIV franchise are likely to keep a lid on the shares, Sutcliffe tells investors in a research note. Further, she believes consensus estimates for 2019 are "slightly too high."
05/13/19
JEFF
05/13/19
NO CHANGE
Target $95
JEFF
Buy
Gilead shares reflect 'undue bearish outlook,' says Jefferies
Gilead Sciences (GILD) is trading at a 10 times price-to-earnings multiple, which reflects an "undue bearish outlook," Jefferies analyst Michael Yee tells investors in a research note. He thinks the company's base HIV business growing to 2025 and then eroding is worth $60-$65 per share, and the rest of business -- HCV, filgotinib, Yescarta -- is worth $15-$20 per share. This implies the stock should be at $80-$85, says Yee. A bear case on the HIV business is $35-$40 per share, which assumes a full cliff post 2025 or GlaxoSmithKline (GSK) taking "massive" share with doublets and long-acting, adds the analyst. Yee keeps a Buy rating on Gilead with a $95 price target.

TODAY'S FREE FLY STORIES

SPY

SPDR S&P 500 ETF Trust

$292.64

0.31 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

14:43
06/19/19
06/19
14:43
06/19/19
14:43
General news
Powell says 'law is clear I have a 4-year term,' 'fully intend to serve it' »

Asked how he would react…

SPY

SPDR S&P 500 ETF Trust

$292.64

0.31 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:42
06/19/19
06/19
14:42
06/19/19
14:42
Conference/Events
Stephens retail/broadlines analyst to hold a luncheon meeting »

Retail/Broadlines Analyst…

DIS

Disney

$140.09

0.88 (0.63%)

14:41
06/19/19
06/19
14:41
06/19/19
14:41
Periodicals
More layoffs from Disney and 20th Century Fox film divisions, Variety reports »

Matt Donelly and Brent…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

SPY

SPDR S&P 500 ETF Trust

$292.48

0.15 (0.05%)

, SPX

S&P 500

$0.00

(0.00%)

14:40
06/19/19
06/19
14:40
06/19/19
14:40
General news
Powell says will be monitoring 'cross-currents,' but would 'like to see more' »

"Many" on the…

SPY

SPDR S&P 500 ETF Trust

$292.48

0.15 (0.05%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:40
06/19/19
06/19
14:40
06/19/19
14:40
Conference/Events
Stephens telecom, media & tech analyst to hold a luncheon »

Analysts hold a…

AAPL

Apple

$198.16

-0.36 (-0.18%)

, GS

Goldman Sachs

$195.66

0.68 (0.35%)

14:38
06/19/19
06/19
14:38
06/19/19
14:38
Periodicals
Apple expanding Goldman Sachs card test, Bloomberg reports »

Apple (AAPL) has launched…

AAPL

Apple

$198.16

-0.36 (-0.18%)

GS

Goldman Sachs

$195.66

0.68 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 09

    Jul

  • 16

    Jul

RHHBY

Roche

$0.00

(0.00%)

14:38
06/19/19
06/19
14:38
06/19/19
14:38
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry conference call »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 27

    Jun

  • 06

    Aug

  • 18

    Aug

  • 19

    Aug

  • 26

    Aug

  • 26

    Aug

  • 02

    Sep

  • 04

    Nov

SPY

SPDR S&P 500 ETF Trust

$292.77

0.44 (0.15%)

, SPX

S&P 500

$0.00

(0.00%)

14:37
06/19/19
06/19
14:37
06/19/19
14:37
General news
Powell says must rely on 'imperfect' inflation expectation proxies »

Fed Chair Powell said…

SPY

SPDR S&P 500 ETF Trust

$292.77

0.44 (0.15%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$71.04

-0.13 (-0.18%)

, YELP

Yelp

$32.80

-0.13 (-0.39%)

14:36
06/19/19
06/19
14:36
06/19/19
14:36
Conference/Events
Wedbush SMid Internet analyst to hold a luncheon meeting »

SMID Internet Analyst…

GRUB

GrubHub

$71.04

-0.13 (-0.18%)

YELP

Yelp

$32.80

-0.13 (-0.39%)

BWLD

Taken private 2/18

$0.00

(0.00%)

CAKE

Cheesecake Factory

$44.35

-1.2 (-2.63%)

BJRI

BJ's Restaurants

$41.00

-1.6 (-3.76%)

CMG

Chipotle

$731.31

-1.41 (-0.19%)

JACK

Jack in the Box

$84.75

-1.61 (-1.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

14:35
06/19/19
06/19
14:35
06/19/19
14:35
General news
FOMC forecast Revisions »

FOMC forecast Revisions…

SPY

SPDR S&P 500 ETF Trust

$293.00

0.67 (0.23%)

, SPX

S&P 500

$0.00

(0.00%)

14:33
06/19/19
06/19
14:33
06/19/19
14:33
General news
Powell says Fed made 'significant' changes to policy statement »

Fed Chair Jerome Powell…

SPY

SPDR S&P 500 ETF Trust

$293.00

0.67 (0.23%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INGN

Inogen

$70.97

-0.13 (-0.18%)

14:32
06/19/19
06/19
14:32
06/19/19
14:32
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Aug

  • 26

    Aug

BJRI

BJ's Restaurants

$41.14

-1.46 (-3.43%)

, CAKE

Cheesecake Factory

$44.50

-1.05 (-2.31%)

14:29
06/19/19
06/19
14:29
06/19/19
14:29
Conference/Events
Wedbush restaurants analyst to hold an analyst/industry conference call »

Restaurants Analyst…

BJRI

BJ's Restaurants

$41.14

-1.46 (-3.43%)

CAKE

Cheesecake Factory

$44.50

-1.05 (-2.31%)

CMG

Chipotle

$729.53

-3.19 (-0.44%)

DIN

Dine Brands

$95.61

-0.39 (-0.41%)

DRI

Darden

$117.36

-0.58 (-0.49%)

JACK

Jack in the Box

$84.90

-1.46 (-1.69%)

SBUX

Starbucks

$83.34

0.39 (0.47%)

TXRH

Texas Roadhouse

$52.30

-1.07 (-2.00%)

WEN

Wendy's

$19.44

0.03 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

  • 20

    Jun

  • 20

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 23

    Jul

  • 08

    Aug

  • 14

    Aug

  • 27

    Aug

  • 28

    Aug

  • 13

    Nov

14:27
06/19/19
06/19
14:27
06/19/19
14:27
Conference/Events
William Blair financial services/insurance analyst to hold a luncheon »

Financial…

CTSH

Cognizant

$63.45

-0.27 (-0.42%)

14:25
06/19/19
06/19
14:25
06/19/19
14:25
Options
Cognizant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jun

14:25
06/19/19
06/19
14:25
06/19/19
14:25
General news
More from the FOMC: a couple of other tweaks the statement »

More from the FOMC: a…

14:24
06/19/19
06/19
14:24
06/19/19
14:24
Conference/Events
CLSA Asian tech analysts to hold an analyst/industry conference call »

Asian Technology Analysts…

UNH

UnitedHealth

$250.20

4.55 (1.85%)

, DVA

DaVita

$51.25

1.49 (2.99%)

14:23
06/19/19
06/19
14:23
06/19/19
14:23
Periodicals
Breaking Periodicals news story on UnitedHealth, DaVita »

FTC set to approve sale…

UNH

UnitedHealth

$250.20

4.55 (1.85%)

DVA

DaVita

$51.25

1.49 (2.99%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

TSLA

Tesla

$227.28

2.6 (1.16%)

14:22
06/19/19
06/19
14:22
06/19/19
14:22
Hot Stocks
Tesla CEO says $1,000 charge for black vehicles to start next month »

Elon Musk, CEO of Tesla,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,105.94

1.54 (0.14%)

, GOOGL

Alphabet Class A

$1,107.59

2.37 (0.21%)

14:21
06/19/19
06/19
14:21
06/19/19
14:21
Periodicals
FTC in late stages of YouTube probe over children content, Washington Post says »

The Federal Trade…

GOOG

Alphabet

$1,105.94

1.54 (0.14%)

GOOGL

Alphabet Class A

$1,107.59

2.37 (0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 19

    Jun

  • 19

    Jun

  • 09

    Jul

  • 10

    Jul

  • 27

    Oct

SYNL

Synalloy

$16.52

-0.27 (-1.61%)

14:21
06/19/19
06/19
14:21
06/19/19
14:21
Earnings
Synalloy lowers FY19 revenue view to $329M from prior $340M »

Adjusted EBITDA for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$55.26

0.6 (1.10%)

14:20
06/19/19
06/19
14:20
06/19/19
14:20
Conference/Events
CVS Health participates in a conference call with Morgan Stanley »

Healthcare Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

14:20
06/19/19
06/19
14:20
06/19/19
14:20
General news
FX Action: The dollar »

FX Action: The dollar…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
06/19/19
06/19
14:17
06/19/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
06/19/19
06/19
14:16
06/19/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.